Drug Profile
GPh 401
Alternative Names: GPh-401Latest Information Update: 25 Aug 2023
Price :
$50
*
At a glance
- Originator GEROPHARM
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 25 Aug 2023 Discontinued - Preclinical for Unspecified (In adolescents, In children, In infants, In neonates) in Russia (unspecified route) (GEROPHARM pipeline, August 2023)
- 28 Jan 2020 No recent reports of development identified for preclinical development in Unspecified(In adolescents, In children, In infants, In neonates) in Russia
- 18 Dec 2015 Preclinical trials in Undefined indication (In adolescents, In infants, In children, In neonates) in Russia (unspecified route) prior to December 2015 (GEROPHARM pipeline, December 2015)